Skip to main content
← Back to Blog
prior-authbillingappealsinsurance

Prior Authorization Denial Recovery Playbook: Win More Appeals in Less Time

August 7, 2026·9 min read·Krasyn

Prior auth denials are not final decisions—they are the beginning of a negotiation. This playbook covers the appeal types, timelines, documentation requirements, and peer-to-peer strategies that reverse the most common denials.

The Scale of the Problem

The American Medical Association's 2024 Prior Authorization Physician Survey found that physicians complete an average of 45 prior authorization requests per physician per week. Denial rates for initial PA requests range from 7% (Medicare fee-for-service) to 26% (commercial managed care) to 35% (Medicare Advantage plans). Of those denied, 82% are ultimately approved on appeal—which means the initial denial is frequently a process failure, not a clinical one.

The cost of this process is not just administrative. Delayed care has clinical consequences: the same AMA survey found that 94% of physicians reported PA delays led to negative outcomes for patients, including hospitalization and emergency department visits that could have been avoided.

Four Types of Appeals—Know Which One to File

1. Internal First-Level Appeal

This is the standard first step. You submit a written appeal to the payer within the denial notice's specified timeframe (typically 30–60 days for commercial payers, 60 days for Medicare Advantage plans). The appeal is reviewed by a payer clinical reviewer—often a nurse or pharmacist, depending on the issue type.

Required elements for a strong first-level appeal:

  • Copy of the original denial letter
  • Clinical notes supporting medical necessity (office visits, relevant labs, imaging reports)
  • Peer-reviewed literature supporting the treatment (PubMed citations, specialty society guidelines)
  • Letter of medical necessity on practice letterhead, signed by the treating physician
  • Failure documentation (if step therapy was required, document doses tried, durations, and outcomes)

2. Peer-to-Peer (P2P) Review

Most payers offer a peer-to-peer option where the treating physician speaks directly with the payer's medical reviewer. P2P reviews overturn initial denials 40–70% of the time when conducted promptly and with strong clinical framing. Request a P2P within 24–48 hours of receiving a denial—do not wait until the standard appeal deadline.

P2P call strategy:

  1. Know the denial reason code exactly (found in the denial letter)
  2. Have the patient's chart open during the call
  3. Lead with clinical outcome data and specialty society guideline citations
  4. If step therapy was denied: cite the specific contraindication, adverse event, or treatment failure from the chart
  5. Ask the reviewer: "What specific clinical information would change your decision?"—this scopes the gap clearly
  6. Document the reviewer's name, title, and the outcome of the call immediately after

3. External Independent Review

If the internal appeal fails, most states require payers to offer external review by an independent review organization (IRO) not affiliated with the payer. Under the ACA, external review is available for non-grandfathered group health plans. For Medicare Advantage denials, this is called a Qualified Independent Contractor (QIC) review at the third level of appeal.

External review overturn rates are lower (15–30%) but remain meaningful. IROs and QICs review only clinical appropriateness—they are not bound by the payer's coverage policies—so a denial based on a restrictive formulary or step therapy protocol may be overturned if the evidence supports the requested treatment.

4. Expedited Appeal (Urgent/Emergency)

When the standard appeal timeline would jeopardize the patient's health, file an expedited appeal. Criteria: the patient's condition would seriously deteriorate or the patient is unable to be discharged from an acute care setting. Payers must respond to expedited appeals within 72 hours (commercial) or 72 hours (Medicare Advantage). CMS requires Medicare Advantage plans to notify enrollees of their expedited appeal rights for any denial of a service.

Medicare Advantage Appeal Timelines

Medicare Advantage Appeal Process and Timelines
Appeal LevelWho ReviewsStandard TimelineExpedited Timeline
Level 1: Plan RedeterminationMA plan internal reviewer60 days from denial72 hours
Level 2: QIC ReviewQualified Independent Contractor60 days from Level 1 denial72 hours
Level 3: ALJ HearingAdministrative Law Judge (if >$180 at issue)Requested within 60 days of Level 2 denialN/A
Level 4: Medicare Appeals CouncilDAB Medicare Appeals Council60 days from ALJ decisionN/A
Level 5: Federal District CourtFederal court (if >$1,870 at issue)60 days from Level 4N/A

The Most Commonly Denied Services—and Why Appeals Win

GLP-1 Agonists (Semaglutide, Tirzepatide)

Denial reason: Step therapy not completed, formulary exclusion, or BMI threshold not met.

Appeal strategy: Document BMI, comorbidities (T2DM, hypertension, PCOS, sleep apnea), prior medications tried (metformin, topiramate, orlistat) with dates, doses, and discontinuation reasons. Cite ADA 2024 Standards of Care and SURMOUNT trial data. Many commercial payers have updated their criteria after 2023 FDA approval of tirzepatide for obesity—verify the current policy before filing.

Advanced Imaging (MRI, CT)

Denial reason: Not medically necessary; alternative study not performed first.

Appeal strategy: Document the specific clinical question the imaging answers that an alternative study (X-ray, ultrasound) cannot. Include red flag symptoms, neurological findings on exam, or failed conservative therapy timelines. Radiology Appropriateness Criteria (American College of Radiology) are authoritative references.

Specialty Medications (Biologics, DMARDs)

Denial reason: Step therapy (methotrexate, sulfasalazine not tried first); prior authorization criteria not met.

Appeal strategy: Document disease activity scores (DAS28, CDAI, BASDAI for ankylosing spondylitis, HBI for Crohn's), prior DMARD failures with specific side effects or inadequate response, and specialty society position statements. ACR, AGA, and EULAR guidelines are payer-recognized authoritative sources.

Home Health Services

Denial reason: Patient not homebound; services not medically necessary.

Appeal strategy: Document homebound status with specific language from the Medicare definition (leaving home requires "considerable and taxing effort"), clinical justification for each skilled service ordered, and functional status assessment (FIM or Barthel Index scores). The Jimmo v. Sebelius settlement established that Medicare home health is available for maintenance therapy—cite it when the denial implies progress is required.

Building a Denial Recovery System in Your Practice

Track Every Denial

Most practices do not know their actual denial rate by payer, service, or denial reason code. Without this data, you cannot prioritize your appeal effort. At minimum, track: payer name, denial reason code (often 3-digit code in the denial letter), date of denial, date of appeal, and outcome.

Create Letter Templates

The most effective appeal letters share a common structure: clinical background, specific denial reason addressed, clinical evidence supporting medical necessity, and a specific ask. Build templates for your top 5 denial categories and fill in patient-specific details rather than writing each letter from scratch.

Set a P2P Policy

Establish an office policy that any denial of a service the physician considers clinically appropriate triggers an immediate P2P request—not a written appeal first. P2P has the highest overturn rate and the fastest timeline. The physician who made the clinical decision is the right person to make that call.

How Krasyn Supports Prior Auth

Krasyn's prior authorization module tracks PA status by patient and payer, flags upcoming expirations, and surfaces denial reasons with suggested appeal documentation from the patient's chart. See the prior auth workflow or review pricing.

Krasyn: Built for Independent Physicians

AI ambient documentation, real-time billing review, and clinical coding support—all in one platform.